ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,040,748 | -21.5% | 1,163,760 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $8,971,414 | +69306.0% | 1,156,110 | -49.0% | 0.00% | -42.9% |
| Q1 2023 | $12,926 | +16.5% | 2,267,642 | +20.4% | 0.01% | +16.7% |
| Q4 2022 | $11,097 | -99.8% | 1,883,978 | +23.2% | 0.01% | +100.0% |
| Q3 2022 | $4,892,000 | -24.3% | 1,528,608 | +6.0% | 0.00% | -25.0% |
| Q2 2022 | $6,460,000 | +220.4% | 1,441,977 | +282.0% | 0.00% | +300.0% |
| Q1 2022 | $2,016,000 | -50.8% | 377,491 | +62.8% | 0.00% | -66.7% |
| Q2 2021 | $4,101,000 | +35.6% | 231,853 | +87.8% | 0.00% | +50.0% |
| Q1 2021 | $3,025,000 | -12.3% | 123,457 | +21.2% | 0.00% | 0.0% |
| Q4 2020 | $3,448,000 | +463.4% | 101,862 | +315.9% | 0.00% | +100.0% |
| Q3 2020 | $612,000 | – | 24,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |